Metipranolol hydrochloride is a non-selective β adrenergic receptor blocking agent.
In Vitro
Metipranolol is used systemically for the treatment of arterial hypertension and topically for the management of glaucoma. MCE has not independently confirmed the accuracy of these methods. They are for reference only.